A recap of the Fall 2025 Group Meeting, trial results from ESMO, and a look ahead to the ASH Annual Meeting and Exposition and the San Antonio Breast Cancer Symposium
A welcome to the new National Cancer Institute director, an update on the federal budget and its implications, and a look ahead to next week's Group Meeting